2014 March

1. IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol. 2013 Jan 15;190(2):521-5.

M23. Recent progress and challenges in the computer-aided design of inhibitors for influenza A M2 channel proteins. Med Chem Res.2014 March 02.


5. Effective peer education in HIV: defining factors that maximise success. Sex Health. 2013 Aug;10(4):325-31.

7. Barriers to participation in actual HIV vaccine trials. Current HIV Research. 2013 Apr;11(3):238-45.

Figure_1_WBF9. Cytotoxic effect of efavirenz is selective against cancer cells and associated with the cannabinoid system. AIDS. 2013 Aug 24;27(13):2031-40.




fog211. A Novel Anti-HIV Active Integrase Inhibitor with a Favorable In Vitro Cytochrome P450 and Uridine 5′-diphospho-glucuronosyltransferase Metabolism Profile. Antiviral Research, 2013, 98, 365-372.

14. A small-molecule inhibitor of hepatitis C virus infectivity. Antimicrob Agents Chemother. 2014 Jan;58(1):386-96.

17. Clinical risk factors of death from pneumonia in children with severe acute malnutrition in an urban critical care ward of Bangladesh. PLoS One. 2013 Sep 9;8(9):e73728.

19. Clinical significance of serum hyaluronan in chronic fibrotic interstitial pneumonia. Respirology. 2013 Nov;18(8):1236-43.

20. Nilotinib-mediated mucosal healing in a rat model of colitis. World J Gastroenterol. 2013 Oct 7;19(37):6237-44.

21. Bioethical issues on the role of contemporary gynecologists concerning HPV vaccination. Eur J Gynaecol Oncol. 2013;34(3):218-21.

Figure23. Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice. Vaccine 2013 Nov;31(48):5729-5735.

25. Screening pregnant women for group B streptococcus infection between 30 and 32 weeks of pregnancy in a population at high risk for premature birth. Int J Gynaecol Obstet. 2013 Jul;122(1):9-12.

27. Serum oxidative-anti-oxidative stress balance is dysregulated in patients with hepatitis C virus-related hepatocellular carcinoma. Hepatol Res. 2013 Oct;43(10):1078-92.

29. A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy. Clin Ther. 2013 Jul;35(7):904-14.

2. Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu. Infect Immun. 2014 Jan;82(1):243-52.

figure4. Development of the preterm gut microbiome in twins at risk of necrotising enterocolitis and sepsis. PLoS One. 2013 Aug 30;8(8):e73465.




6. Sex differences in HIV-1 viral load and absolute CD4 cell count in long term survivors HIV-1 infected patients from Giurgiu, Romania. Rev Romana Med Lab.2013 Jun;21(2-4):217-224.

8. Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan. Intern Med. 2013;52(24):2701-6.

10. Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae. Int J Antimicrob Agents. 2013 Jul;42(1):19-26.

12. Bifunctional anti-HIV/TB inhibitors: perspective from in-silico design and molecular dynamics simulations. Letters in Drug Design and Discovery, 10, 706-712.

Webber-2014-World-Biomed-Fron15. Nerve growth factor acts through the TrkA receptor to protect sensory neurons from the damaging effects of the HIV-1 viral protein, Vpr. Neuroscience. 2013 Nov 12;252:512-25.


16. Assessment of viral genotype impact to the cost-effectiveness and overall costs of care for PEG-interferon-2α + ribavirine treated chronic hepatitis C patients. Hepat Mon. 2013 Jun 19;13(6):e6750.

18. Immunoglobulin G4-related lung disease accompanied by organizing pneumonia. Intern Med. 2013;52(18):2105-11.

22. The temporal trend of influenza-associated morbidity and the impact of early appearance of antigenic drifted strains in a Southeast Asian country. PLoS One. 2014 Jan 8;9(1):e84239.

Rostyslav Bilyy fig224. Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn’s disease patients. J Med Chem. 2013 Jul 11;56(13):5395-406.


26. Maintenance of the remission stage of Crohn’s disease with adalimumab therapy during pregnancy. Intern Med. 2013;52(10):1049-53.

28. Development of a rapid phage-based method for the detection of viable Mycobacterium avium subsp. paratuberculosis in blood within 48 h. J Microbiol Methods. 2013 Sep;94(3):175-9.

30. Effect of Cyclophosphamide on the immune status of chickens vaccinated with Newcastle disease vaccine. Res J Biotechnol.2014 Jan;9(1):53-56.

 

http://biomedfrontiers.org/infection-2014-march/

Infection and Immunity

2016 Dec

1. Capsule Design for Blue Light Therapy against Helicobacter pylori. PLoS One. 2016 Jan 27;11(1):e0147531.

3. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection. PLoS One. 2016 Feb 12;11(2):e0148824.

5. Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma. World J Gastroenterol. 2016 Feb 28;22(8):2630-5.

7. Validation of research trajectory 1 of an Exposome framework: Exposure to benzo(a)pyrene confers enhanced susceptibility to bacterial infection. Environ Res. 2016 Apr;146:173-84.

9. Clinical Outcomes of Patients with HIV Undergoing Lead Extraction for Infectious and Noninfectious Indications. Pacing Clin Electrophysiol. 2016 Feb;39(2):122-7.

11. Persistence of non-typeable Haemophilus influenzae in the pharynx of children with adenotonsillar hypertrophy after treatment with azithromycin. Pathogens and Disease. 2016 Feb;74(1):ftv106.

14. Development of an in vitro model of the early-stage bovine tuberculous granuloma using Mycobacterium bovis-BCG. Vet Immunol Immunopathol. 2015 Dec 15;168(3-4):249-57.

15. Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies. AIDS Res Hum Retroviruses. 2016 Feb;32(2):178-86.

17. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID “Meet the Experts” 2015 Workshop Summary. AIDS Res Hum Retroviruses. 2016 Feb;32(2):109-19.

19. “My Favourite Day Is Sunday”: Community Perceptions of (Drug-Resistant) Tuberculosis and Ambulatory Tuberculosis Care in Kara Suu District, Osh Province, Kyrgyzstan. PLoS One. 2016 Mar 28;11(3):e0152283.

21. Emergence of reticuloendotheliosis virus in pigeons in Guangdong province, southern China. Arch Virol. 2016 Jul;161(7):2007-2011.

23. Nonactivated Protein C in the Treatment of Neonatal Sepsis: A Retrospective Analysis of Outcome. Pediatr Infect Dis J. 2016 Sep;35(9):967-71.

25. The Phospholipid:Diacylglycerol Acyltransferase Lro1 Is Responsible for Hepatitis C Virus Core-Induced Lipid Droplet Formation in a Yeast Model System. PLoS One. 2016 Jul 26;11(7):e0159324.

27. Antigen Receptor-Intrinsic Non-Self: The Key to Understanding Regulatory Lymphocyte-Mediated Idiotypic Control of Adaptive Immune Responses. Crit Rev Immunol. 2016;36(1):13-56.

 

 

2. Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology. Biomed Res Int. 2016;2016:7985104.

4. Detection of natural infection of Leishmania donovani (Kinetoplastida: Trypanosomatidae) in Phlebotomus argentipes (Diptera: Psychodidae) from a forest ecosystem in the Western Ghats, India, endemic for cutaneous leishmaniasis. Acta Trop. 2016 Apr;156:95-9.

6. Social class based on occupation is associated with hospitalization for A(H1N1)pdm09 infection. Comparison between hospitalized and ambulatory cases. Epidemiol Infect. 2016 Mar;144(4):732-40.

8. Efficacy and persistent activity of moxidectin against natural Muellerius capillaris infection in goats and pathological consequences of muelleriosis. Vet Parasitol. 2016 Mar 15;218:98-101.

10. Neutrophil-to-lymphocyte ratio in the differential diagnosis of acute bacterial meningitis. Eur J Clin Microbiol Infect Dis 2016 Mar; 35(3):397-403.

12. A Putative Non-Canonical Ras-Like GTPase from P. falciparum: Chemical Properties and Characterization of the Protein. PLoS One. 2015 Nov 5;10(11):e0140994.

16. Characterization of a serine hydrolase targeted by acyl-protein thioesterase inhibitors in Toxoplasma gondii. J Biol Chem. 2013 Sep 20;288(38):27002-18.

18. Spondylodiscitis severity code: scoring system for the classification and treatment of non-specific spondylodiscitis. Eur Spine J. 2016 Apr;25(4):1012-20.

20. TLR4 induces CCR7-dependent monocytes transmigration through the blood-brain barrier. J Neuroimmunol. 2016 Jun 15;295-296:12-7.

22. PGC-1α-Dependent Mitochondrial Adaptation Is Necessary to Sustain IL-2-Induced Activities in Human NK Cells. Mediators Inflamm. 2016;2016:9605253.

24. Modeling and predicting drug resistance rate and strength. Eur J Clin Microbiol Infect Dis.2016 Aug;35(8):1259-1267.

26. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus. J Virol Methods.2016 Sep;235:105-111

 

 



BREAKING NEWS: EDITORS’ PICKS

New analysis of the influenza A virus shows potential for developing new anti-viral drugs which are more likely to be universally effective against the flu virus originating from avian, swine or human virus strains.

Around 1 in 5 of the population were infected in both recent outbreaks of seasonal flu and the 2009 H1N1 influenza pandemic, but just 23% of these infections caused symptoms, and only 17% of people were ill enough to consult their doctor.

One person having a rare combination of both lupus and HIV, has the unique ability to fight HIV. This provided key insights into an immune response that researchers now hope to trigger with a vaccine, according to new findings.

The immune cells of 12 HIV positive patients have been successfully genetically engineered by researchers to resist infection, and decrease the viral loads of some patients taken off antiretroviral drug therapy (ADT) entirely -— including one patient whose levels became undetectable. This it the first published report of any gene editing approach in humans.

A KwaZulu-Natal woman’s body responded to her HIV infection by making potent antibodies (called broadly neutralizing antibodies, because they are able to kill multiple strains of HIV from across the world). Researchers identified these antibodies in her blood and then duplicated them by cloning the antibodies in the laboratory. The cloned antibodies were then used in a series of experiments in the laboratory to elucidate the pathway followed by her immune system to make these potent antibodies.

The antibiotics, called spectinamides, were created by changing the chemical structure of an existing antibiotic, spectinomycin, which does not work against TB.

 

Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann